Hedge Fund - Acuta Capital Partners
Enliven Therapeutics Inc ()
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $5,220,494 | 6.05% | 265,269 | $ |
| 2 | 2024 - Q4 (2024-12-31) | $6,015,780 | 6.05% | 267,368 | $ |
| 3 | 2024 - Q3 (2024-09-30) | $7,569,239 | 6.13% | 296,368 | $ |
| 4 | 2024 - Q2 (2024-06-30) | $9,294,202 | 7.82% | 397,698 | $ |
| 5 | 2024 - Q1 (2024-03-31) | $6,967,381 | 4.52% | 396,099 | $ |
| 6 | 2023 - Q4 (2023-12-31) | $1,714,444 | 0.96% | 123,876 | $ |
| 7 | 2023 - Q3 (2023-09-30) | $1,415,176 | 0.94% | 103,600 | $ |
| 8 | 2023 - Q2 (2023-06-30) | $2,132,845 | 1.44% | 104,500 | $ |
| 9 | 2023 - Q1 (2023-03-31) | $678,440 | 0.49% | 30,979 | $ |
The displayed share prices are average quarterly stock market prices.